Neoadjuvant chemotherapy instead of upfront surgery for neoplastic cells, circulating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Jan 2024: Trial started, NCT06391892
  2. 30 Apr 2024: Trial registered, NCT06391892

The trials

NCT06391892: Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

State
Under way
Phase
Phase 2
People
100 planned
Started
11 Jan 2024
Primary completion
1 Jun 2026
Arms
ctDNA+ _ctDNA guided
Results
None posted
  1. 11 Jan 2024: Trial started
  2. 30 Apr 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Surgery or procedure.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.